Following the discovery of BRCA1/2, it was apparent that these 2 genes were not responsible for all familial cases of breast and ovarian cancer.12 Hereditary cancer panel testing is designed to detect mutations in a menu of genes that might contribute to cancer risk and can identify a more robust population of women at increased risk of cancer. The gene discussed is BRCA1; the disease is ovarian cancer.